Descrizione

Enzyme replacement therapy (ERT) effects on gastrointestinal symptoms in Fabry disease patients are reviewed, showing variable symptom improvement across studies.

Figure 4

Chart

Source Paper

Gastrointestinal Involvement in Anderson-Fabry Disease: A Narrative Review.

International journal of environmental research and public health (2021)

PMID: 33807115

DOI: 10.3390/ijerph18063320

Cite This Figure

![Figure 4: Enzyme replacement therapy (ERT) effects on gastrointestinal symptoms in Fabry disease patients are reviewed, showing variable symptom improvement across studies.]()

> Source: Fabio Caputo et al. "Gastrointestinal Involvement in Anderson-Fabry Disease: A Narrative Review.." *International journal of environmental research and public health*, 2021. PMID: [33807115](https://pubmed.ncbi.nlm.nih.gov/33807115/)

<figure>
  <img src="" alt="Enzyme replacement therapy (ERT) effects on gastrointestinal symptoms in Fabry disease patients are reviewed, showing variable symptom improvement across studies." />
  <figcaption>Figure 4. Enzyme replacement therapy (ERT) effects on gastrointestinal symptoms in Fabry disease patients are reviewed, showing variable symptom improvement across studies.<br>  Source: Fabio Caputo et al. "Gastrointestinal Involvement in Anderson-Fabry Disease: A Narrative Review.." <em>International journal of environmental research and public health</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33807115/">33807115</a></figcaption>
</figure>

Evidenze correlate

Alpha-Galactosidase per Bloating and Intestinal Gas

Grado B · 4 studi

Alpha-Galactosidase per Irritable Bowel Syndrome (IBS)

Grado D · 1 studi